Please use this identifier to cite or link to this item: http://111.93.178.142:25000/jspui/handle/123456789/5575
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAnuradha G. More-
dc.date.accessioned2026-07-03T09:27:48Z-
dc.date.available2026-07-03T09:27:48Z-
dc.date.issued2026-07-03-
dc.identifier.urihttp://111.93.178.142:25000/jspui/handle/123456789/5575-
dc.descriptionVol. 63, No. 5, p 7en_US
dc.language.isoenen_US
dc.subjectCervicalcanceren_US
dc.subjectmetastaticen_US
dc.subjectEGFRen_US
dc.subjectEpidemal Growth Factor Reseptoren_US
dc.subjectHPVen_US
dc.subjectHuman Papillomavirusen_US
dc.subjectVEGFen_US
dc.subjectVascular Endothelial Growth Factoren_US
dc.subjectTargeted therapyen_US
dc.titleUpcoming strategies for recurrent and methastatic cervical canceren_US
dc.typeOtheren_US
Appears in Collections:Vol63, No. 5, 2026

Files in This Item:
File Description SizeFormat 
1.pdfVol. 63, No. 5, p 783.11 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.